Skip to content

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03258164
Enrollment
32
Registered
2017-08-23
Start date
2017-03-22
Completion date
2022-11-22
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Hypoplasia and Facial Ageing

Brief summary

The purpose of the present study is to examine whether enrichment of a fat graft with autologous ex vivo expanded ASC injected into the breast tissue or face, both for cosmetic use, will significantly improve the results of conventional lipofilling and synthetic facial fillers, thereby being able to offer a safer, more natural and long-lasting alternative to current artificial solutions for cosmetic patients.

Detailed description

The cosmetic breast augmentation design is a double-blind (surgeon and data assessor) randomized, prospective clinical study on healthy subjects. The cosmetic facial filling design is a data assessor-blinded, randomized, prospective clinical study on healthy subjects.

Interventions

BIOLOGICALASC enriched lipofilling

Fat grafts enriched with ex vivo expanded ASC

BIOLOGICALStandard Lipofilling

Non-ASC enriched fat grafts

Sponsors

Aleris-Hamlet Hospitaler København
CollaboratorOTHER
Stemform
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Criteria breast augmentation: Inclusion criteria 1. Age 18 - 50 years 2. Healthy females 3. BMI 18 - 30 kg/m2 4. 1000 ml of fat (lipoaspirate) available for liposuction at the abdomen and/or thighs 5. Desire for breast augmentation 6. Speaks and reads Danish or English 7. Signed informed consent

Exclusion criteria

1. Smoking 2. Previous breast surgery 3. Previous cancer or predisposition to breast cancer 4. Pregnancy or planned pregnancy within one year after the procedure 5. Breastfeeding less than 6 months prior to inclusion 6. Weight gain or loss above 2 BMI point 7. Known chronic disease associated with metabolism malfunction or pour healing 8. Pacemaker or other implanted foreign objects 9. Allergy towards necessary anaesthesia 10. Intention of weight loss or weight gain within the trial period Criteria fascial filling Inclusion criteria 1. Age 25 - 65 years 2. Healthy females 3. BMI 18 - 30 kg/m2 4. 100 ml of fat (lipoaspirate) available for liposuction at the abdomen and/or thighs 5. Desire for facial wrinkle treatment and facial augmentation (rejuvenation) 6. Speaks and reads Danish or English 7. Signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in volume over time after breast augmentationBaseline, four and twelve monthsMeasurement of the residual volume of fat transplants as based on MRI before operation (baseline), and four and twelve months after lipo-injection to the breast in order to determine the difference in volume between baseline and 4 months and 12 months post operative; and thereby the resorption rate over time.

Secondary

MeasureTime frameDescription
Change in cosmetic facial appearance over time after facial fillingBaseline, one, four and twelve monthsAssessment of cosmetic outcome based on clinical photos before (baseline), one, four and twelve months after the procedure when compared to baseline, evaluated by 5 independent plastic surgeons blinded to the intervention using a scale of 1-5 to determine the difference in appearance over time.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026